"Maybe but according to these initial results - ZLD outperforms Lyrica"
Yup, totally agree there from what they said.
Now (imo) they'll probably look at doing a CR on the back of the improving sp (and sentiment) to pitch themselves against the top-selling generics.
If their confidence is that strong, they should really not waste any time and go straight to the FDA.
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica, page-35
-
- There are more pages in this discussion • 183 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
73.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.340M | |||
| Open | High | Low | Value | Volume |
| 72.0¢ | 73.5¢ | 72.0¢ | $2.874K | 3.985K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1251 | 72.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.5¢ | 13897 | 2 |
View Market Depth
| Last trade - 11.45am 04/09/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |